Market Tracker

05/24 5:16pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

1.46
Delayed Data
As of 3:59pm ET
 -0.07 / -4.58%
Today’s Change
1.08
Today|||52-Week Range
4.11
-10.98%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close1.53
Today’s open1.54
Day’s range1.46 - 1.64
Volume174,321
Average volume (3 months)119,742
Market cap$44.3M
Dividend yield--
Data as of 3:59pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-12.82%
Earnings growth (this year)+6.06%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.52

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc-0.07-7.22%
TTHITransition Therapeut...-0.03-3.61%
INISInternational Isotop...+0.00+0.50%
TROVUTrovagene Inc0.000.00%
Data as of 3:58pm ET, 05/24/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$20.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts